Skip to main content
Fintax RCM Logo

Endocrinology Billing Specialists

Endocrinology Billing - Stop Leaving Diabetes-Care Revenue on the Table

Your practice does real work managing glucose monitors, insulin pumps, thyroid procedures, and diabetes education - and much of it gets underpaid or never billed. We handle diabetes management, thyroid, and hormone-therapy billing end to end, so your revenue matches the care you provide and your team stays focused on patients.

Where the month stops being billableIllustrative sample

Patient consents to the program

Care plan recorded and dated

Time logged as it is spent

Threshold met for the month

Month billed

The work was done. The third link is where it stops being billable, because time that was not written down as it passed cannot be reconstructed afterwards.

How We Overhaul Endocrinology Billing

We handle the full endocrinology billing lifecycle - from charge capture through final payment - so your clinical team can focus entirely on patient care.

Step 01

Diabetes Technology and Thyroid Claims Billed Right the First Time

Endocrinology-focused billers handle your glucose-monitor, insulin pump, thyroid procedure, and diabetes-education claims - so fewer come back denied and payment reflects the full course of care.

Glucose-monitor claims matched to the right billing path / Thyroid ultrasound and biopsy structured for full payment / Diabetes education billed only when it will actually pay / Complex visits coded at the level the care supports

Step 02

Device and Specialty-Drug Approvals Cleared Before Treatment Starts

We assemble the payer paperwork that approvals actually turn on - glucose logs, lab results, and prior-therapy history - so patients start on their monitors, pumps, and therapies without weeks of back-and-forth.

Glucose monitor and insulin pump approvals handled up front / Growth hormone and specialty-drug authorizations documented to approve / Denied requests appealed and pursued to a decision / Faster treatment starts and fewer scheduling delays

Step 03

In-Office Drug Revenue Protected

Physician-administered endocrine drugs tie up real money in your inventory. We bill every dose accurately, capture wastage, and confirm coverage - so you recover what those drugs actually cost you.

Every administered dose billed and accounted for / Wasted and overfilled drug documented and recovered / Coverage confirmed before the drug is given / Drug acquisition costs tracked against reimbursement

Step 04

Ongoing Diabetes Management Turned Into Predictable Revenue

Chronic care management, remote monitoring, and monthly glucose-data reviews turn the follow-up care you already provide into a recurring, reliable revenue stream - with the consent and time records payers require.

Monthly chronic-care and remote-monitoring revenue captured / Recurring glucose-data interpretation billed every eligible month / Consent and time-tracking workflows handled for you / A steadier month-to-month cash flow from your existing panel

Hidden Challenges in Endocrinology Billing

Endocrinology practices face unique billing complexities with high-cost diabetes drugs, extensive prior authorizations, and coordination between medical and pharmacy benefits.

1

Continuous Glucose Monitor Work Often Goes Unpaid

Glucose-monitor billing changes depending on who owns the device and whether your physician actually interprets the data. Choose the wrong path for the situation, or bill a setup twice, and the payer denies work your team already performed - quietly turning routine diabetes care into a write-off.

Impact: Denied or underpaid CGM claims for work the practice already performed

2

Monthly Glucose-Data Reviews Get Denied Without the Right Paperwork

Your physicians can be paid for reviewing a patient's glucose data as often as every month - but only when a separate written interpretation is on file. When that report lives only inside the visit note, payers reject the claim, and a recurring revenue stream disappears.

Impact: Monthly interpretation revenue lost to missing reports and frequency denials

3

Insulin Pump Claims Sent to the Wrong Place Sit Unpaid

Pump devices and supplies are covered under one benefit, while the training and management visits are covered under another - each with its own documentation rules. Route a claim to the wrong benefit and payment stalls for weeks or is forfeited entirely.

Impact: Delayed or forfeited payment when pump claims go to the wrong benefit

4

In-Office Thyroid Procedures Are Frequently Underpaid

Thyroid ultrasound and needle biopsies pay very differently depending on how the claim is structured and whether your practice owns the equipment. The wrong structure leaves a meaningful share of the reimbursement with the insurer on every case.

Impact: Underpaid thyroid procedures when global vs. component billing is chosen wrong

5

Diabetes Education You Deliver May Not Be Billable at All

Diabetes self-management training only pays through an accredited program, with a physician order on file, inside Medicare's time limits. Practices that provide the teaching without those pieces in place hand over valuable staff time they can never bill for.

Impact: Unbillable education sessions when accreditation or orders are missing

6

Complex Diabetes and Thyroid Visits Are Chronically Undercoded

A visit that reviews glucose data, adjusts insulin, and manages several interacting conditions supports a higher-paying visit level than most practices bill. Defaulting to the safe, lower level across a whole panel of complex patients compounds into a large annual shortfall - with no denial to warn you it's happening.

Impact: Systematic undercoding of complex chronic visits across the whole panel

Hands-On Endocrinology Billing

Specialty-tuned billing solutions tailored specifically for endocrinology practices and infusion centers.

Diabetes Technology Billing

Billing for CGM setup, training, and interpretation plus insulin pump devices, supplies, and management visits.

CGM technical and interpretation codes / Insulin pump DME billing / Pump training and management visits / Medical necessity support

Thyroid Procedure Billing

Billing for in-office thyroid ultrasound, ultrasound-guided FNA, and biopsy with correct global or split-component billing.

Thyroid ultrasound billing / Fine-needle aspiration billing / Professional/technical component split / Pathology coordination

Chronic Care & Remote Monitoring

Program billing for CCM, RPM, and diabetes self-management training across your Medicare panel.

CCM monthly cycles / RPM device and review billing / Diabetes self-management training billing / Time and consent documentation

Specialty Drug Authorization

Prior authorization and appeals management for endocrine medications, CGM devices, and insulin pumps.

Prior authorization / Medical policy review / Denial appeals / Specialty pharmacy coordination

Inside Endocrinology

01

The Recurring Revenue Most Endocrinology Practices Never Fully Capture

Beyond office visits, your practice can be paid every month for the ongoing diabetes management you already provide. Chronic care management pays for the time your staff spends coordinating care between visits for patients with two or more chronic conditions. Remote patient monitoring pays for setting up a patient's glucose monitor and reviewing the data it sends in.

And your physician's monthly review of that glucose data is billable on its own. Together these programs can add meaningful, predictable revenue per patient each year on top of standard visit income - but only when the consent, care plan, and time records are in place, so most practices leave a large share of it unbilled.

Monthly care-coordination time is billable - but requires consent, a care plan, and around-the-clock patient access

Remote monitoring pays separately for device setup, the monthly device, and the data review

The physician's monthly glucose-data review is billed on its own, separate from the monitoring itself

Capturing this reliably means logging the date, time spent, and service for every qualifying touchpoint

02

Getting Paid in Full for In-Office Thyroid Procedures

In-office thyroid ultrasound and ultrasound-guided needle biopsies are meaningful revenue when billed correctly - and underpaid when they aren't. The payment splits into a piece for performing the procedure and a piece for interpreting it; whether you bill those together or separately depends on who owns the equipment and reads the study.

Choose the wrong structure and the insurer keeps part of what the procedure earned. The rules around these biopsies have also changed in recent years, so a practice billing them the old way may be losing money on every case.

How a thyroid study is billed should follow who owns the equipment and reads the images

Billing the procedure and its interpretation the wrong way underpays every case

The pathologist's read of the biopsy is billed separately from the biopsy itself

Clear documentation of the ultrasound findings supports the claim and prevents denials

03

Protecting the Money Tied Up in In-Office Drugs

Endocrinologists routinely administer injectable medications in the office - osteoporosis agents, growth hormones, hormone therapies, and more. Under the buy-and-bill model, your practice buys these drugs up front, so every dose sitting in inventory is your capital at risk until it's administered and paid for. Billing them accurately, documenting any wasted portion of a single-dose vial, and confirming which benefit covers the drug before it's given is what keeps that capital from turning into a loss - and keeps the practice out of compliance trouble.

Every dose you buy is your money at risk until it's billed and collected

The unused portion of a single-dose vial is documented and billed, not written off

Confirm which insurance benefit covers each drug before administering it

Specialty drugs like growth hormone need approval documented up front or the claim stalls

04

Why Glucose-Monitor Claims Pay or Deny on Three Small Details

Glucose-monitor billing turns on who owns the device and what the physician actually documented. Setup and training for a patient-owned monitor is billable once per device ownership period, not on every sensor change; billing it repeatedly builds a repayment problem. When the practice places its own device, the claim only stands if at least three full days of data were recorded; a failed sensor that captured less isn't billable.

And the physician's analysis of the data pays no more than once per patient per month, and only when it exists as a distinct written report rather than a line inside the visit note. Practices leak in both directions: some give the interpretation away inside the office visit, others bill it on every data glance and invite an audit. Getting all three details right on every claim is the difference between a reliable revenue line and a recurring denial.

Patient-owned device setup is billable once per ownership period, never per sensor change

Practice-placed devices need at least three full days of recorded data before the claim stands

The physician's data analysis pays at most once per patient per month, as its own written report

Billing on every data glance risks repayment; never billing it gives the work away

05

Denied Monitor Coverage Is Worth a Second Look

Medicare's coverage rules for glucose monitors changed substantially in 2023. The old criteria tied coverage to intensive insulin regimens and frequent daily fingerstick testing; the current rules cover patients on any insulin regimen, including basal-only, and certain non-insulin patients with a documented history of problematic low blood sugar.

That means a meaningful group of patients in a typical endocrinology panel were denied under rules that no longer exist. Those denials do not fix themselves - someone has to re-screen the panel against the current criteria, gather the documentation of insulin use or low-blood-sugar history, and resubmit. Commercial plans have followed Medicare's direction unevenly, so each plan's current policy has to be checked rather than assumed. Practices that treat old monitor denials as settled are leaving covered patients on fingersticks and covered revenue unclaimed.

The 2023 rules cover basal-only insulin patients and some non-insulin patients with low-blood-sugar history

Patients denied under the old fingerstick-frequency criteria may qualify today

Re-screening old denials requires documented insulin use or low-blood-sugar episodes, then resubmission

Commercial plans adopted the expansion unevenly, so verify each plan's current policy

06

Diabetes Education Pays Once the Program Is Actually Set Up

Medicare pays for structured diabetes self-management training in half-hour units: up to ten hours in a patient's first benefit year and two hours annually after that, across individual and group sessions. For a diabetes-heavy panel that is real, recurring revenue attached to teaching your staff already does. The barrier is almost never patient eligibility - it's infrastructure.

The program must hold recognized accreditation through the American Diabetes Association or the diabetes-educator association pathway, every patient needs a documented referral from the treating provider, and each session's units have to be logged as they happen. When any of those pieces is missing, the education still gets delivered; it just gets delivered for free.

Standing the program up is a one-time project with a recurring payoff, and keeping the referrals and unit logs clean is what keeps it paying.

Medicare covers up to ten hours of training in the first benefit year, then two hours annually

The program must hold recognized accreditation before a single session is billable

Every patient needs a documented referral from the treating provider on file

Sessions are paid in half-hour units, so unit logging has to happen as care is delivered

What Each Payer Expects

Different payers have distinct requirements for Endocrinology billing. Our billers navigate each payer's rules.

Medicare

Medicare Part B

  • Medicare covers glucose monitors as equipment - get the coverage details right so the device claim pays cleanly
  • Medicare's Diabetes Prevention Program is billed by enrolled program suppliers; a practice must enroll as a supplier to bill it
  • Bone-density screening is covered on a set schedule for older patients - track eligibility so you don't miss billable exams
  • Whether an injectable drug is paid in-office or through pharmacy depends on how it's given; confirm it before you administer
  • An ongoing-care add-on has been payable on qualifying visits since 2024; it fits endocrinology's long-term patients, so confirm it's being captured
  • A follow-up adjusting medications across several chronic conditions supports a higher visit level than the reflexive default; extensive glucose-data review can also set the level by total time on the visit date

Medicaid

Medicaid

  • Diabetes-technology coverage differs by state - verify it before supplying a device so you aren't left unpaid
  • Most Medicaid plans require approval up front for glucose monitors and insulin pumps
  • Some diabetes-related drugs require a documented prior-therapy history before they'll be covered
  • Pediatric diabetes visits are covered under children's benefit programs - bill them under the right pathway

Commercial

Commercial Payers

  • Confirm each plan's device coverage and approval rules before supplying a glucose monitor
  • Many plans require a referral from the primary-care physician before they'll cover specialty visits
  • Osteoporosis drugs typically need fracture-risk documentation on file to win approval
  • Remote-monitoring programs must run on an approved platform and be enrolled with the plan to pay
  • Weight-loss and newer diabetes drugs are among the most tightly managed on commercial formularies, and criteria change yearly, so match documentation to the plan's current policy before submitting
  • Not every plan has matched Medicare's 2023 glucose-monitor coverage expansion, so check each plan's own criteria rather than assuming parity

All payers

Preventive & Wellness Programs

  • A referral to the Diabetes Prevention Program is not billable by itself; only enrolled program suppliers bill the program
  • Annual diabetes eye, foot, and kidney screenings can each be billed separately when documented
  • Nutrition counseling for diabetes is a covered, billable service with the right referral in place
  • Obesity and metabolic-syndrome management opens additional billable visits alongside routine care

Hands-On Endocrinology Billing

Specialty-tuned billing solutions tailored specifically for endocrinology practices and infusion centers.

Diabetes Technology Billing

Billing for CGM setup, training, and interpretation plus insulin pump devices, supplies, and management visits.

CGM technical and interpretation codes / Insulin pump DME billing / Pump training and management visits / Medical necessity support

Thyroid Procedure Billing

Billing for in-office thyroid ultrasound, ultrasound-guided FNA, and biopsy with correct global or split-component billing.

Thyroid ultrasound billing / Fine-needle aspiration billing / Professional/technical component split / Pathology coordination

Chronic Care & Remote Monitoring

Program billing for CCM, RPM, and diabetes self-management training across your Medicare panel.

CCM monthly cycles / RPM device and review billing / Diabetes self-management training billing / Time and consent documentation

Specialty Drug Authorization

Prior authorization and appeals management for endocrine medications, CGM devices, and insulin pumps.

Prior authorization / Medical policy review / Denial appeals / Specialty pharmacy coordination

Frequently Asked Questions About Endocrinology Billing

Expert answers to common questions about endocrinology billing, coding, insurance requirements, and revenue cycle management.

Still Have Questions?

Our team is ready to answer your specific questions and provide personalized guidance for your practice.

Book a Free Consultation

See How Much Revenue Your Endocrinology Practice Is Missing

Get a no-obligation look at how your endocrinology billing stacks up. Our specialists will review your top denial reasons and show you a concrete plan to close the revenue gap.

Endocrinology Coding SpecialistsHIPAA Compliant & SecureDedicated Account Manager